Statement Of Cash Flows [Abstract]

aap Implantate AG - Filing #6496623

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
166,000 EUR
356,000 EUR
Increase (decrease) in working capital
1,247 EUR
177,000 EUR
Adjustments for decrease (increase) in trade and other receivables
204,000 EUR
245,000 EUR
Adjustments for increase (decrease) in trade and other payables
264,000 EUR
254,000 EUR
Adjustments for decrease (increase) in other current assets
0 EUR
0 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issue of bonds, notes and debentures
2,704 EUR
0 EUR
Repayments of bonds, notes and debentures
452,000 EUR
0 EUR
Payments for share issue costs
54,000 EUR
13,000 EUR
Payments for debt issue costs
60,000 EUR
0 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.